Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geiger, J. N.
Right arrow Articles by Wojchowski, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geiger, J. N.
Right arrow Articles by Wojchowski, D. M.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 February 2001, Vol. 97, No. 4, pp. 901-910

HEMATOPOIESIS

mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development

Justin N. Geiger, Geoffry T. Knudsen, Leigh Panek, Ajay K. Pandit, Michael D. Yoder, Kenneth A. Lord, Caretha L. Creasy, Brian M. Burns, Peter Gaines, Susan B. Dillon, and Don M. Wojchowski

From the Departments of Biochemistry & Molecular Biology and Veterinary Science, The Pennsylvania State University, University Park, PA; SmithKline-Beecham Pharmaceuticals, Collegeville, PA; and SmithKline-Beecham Pharmaceuticals, King of Prussia, PA.

DYRKs are a new subfamily of dual-specificity kinases that was originally discovered on the basis of homology to Yak1, an inhibitor of cell cycle progression in yeast. At present, mDYRK-3 and mDYRK-2 have been cloned, and mDYRK-3 has been characterized with respect to kinase activity, expression among tissues and hematopoietic cells, and possible function during erythropoiesis. In sequence, mDYRK-3 diverges markedly in noncatalytic domains from mDYRK-2 and mDYRK-1a, but is 91.3% identical overall to hDYRK-3. Catalytically, mDYRK-3 readily phosphorylated myelin basic protein (but not histone 2B) and also appeared to autophosphorylate in vitro. Expression of mDYRK-1a, mDYRK-2, and mDYRK-3 was high in testes, but unlike mDYRK1a and mDYRK 2, mDYRK-3 was not expressed at appreciable levels in other tissues examined. Among hematopoietic cells, however, mDYRK-3 expression was selectively elevated in erythroid cell lines and primary pro-erythroid cells. In developmentally synchronized erythroid progenitor cells, expression peaked sharply following exposure to erythropoietin plus stem cell factor (SCF) (but not SCF alone), and in situ hybridizations of sectioned embryos revealed selective expression of mDYRK-3 in fetal liver. Interestingly, antisense oligonucleotides to mDYRK-3 were shown to significantly and specifically enhance colony-forming unit-erythroid colony formation. Thus, it is proposed that mDYRK-3 kinase functions as a lineage-restricted, stage-specific suppressor of red cell development.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
X. Deng, D. Z. Ewton, and E. Friedman
Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species
Cancer Res., April 15, 2009; 69(8): 3317 - 3324.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Bogacheva, O. Bogachev, M. Menon, A. Dev, E. Houde, E. I. Valoret, H. M. Prosser, C. L. Creasy, S. J. Pickering, E. Grau, et al.
DYRK3 Dual-specificity Kinase Attenuates Erythropoiesis during Anemia
J. Biol. Chem., December 26, 2008; 283(52): 36665 - 36675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Deng, S. E. Mercer, S. Shah, D. Z. Ewton, and E. Friedman
The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase
J. Biol. Chem., May 21, 2004; 279(21): 22498 - 22504.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Skurat and A. D. Dietrich
Phosphorylation of Ser640 in Muscle Glycogen Synthase by DYRK Family Protein Kinases
J. Biol. Chem., January 23, 2004; 279(4): 2490 - 2498.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Li, M. P. Menon, V. G. Karur, S. Hegde, and D. M. Wojchowski
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells
Blood, November 1, 2003; 102(9): 3147 - 3153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Li, S. Zhao, V. Karur, and D. M. Wojchowski
DYRK3 Activation, Engagement of Protein Kinase A/cAMP Response Element-binding Protein, and Modulation of Progenitor Cell Survival
J. Biol. Chem., November 27, 2002; 277(49): 47052 - 47060.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020